Financial & Investment Management Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-8,727
Closed -$292K 100
2016
Q2
$292K Hold
8,727
0.09% 85
2016
Q1
$245K Buy
8,727
+452
+5% +$12.9K 0.07% 93
2015
Q4
$253K Hold
8,275
0.07% 100
2015
Q3
$247K Hold
8,275
0.07% 110
2015
Q2
$263K Sell
8,275
-7,753
-48% -$253K 0.07% 118
2015
Q1
$529K Buy
16,028
+7,613
+90% +$242K 0.13% 100
2014
Q4
$249K Buy
+8,415
New +$241K 0.07% 107
2014
Q3
Sell
-8,275
Closed -$232K 101
2014
Q2
$233K Hold
8,275
0.07% 98
2014
Q1
$252K Sell
8,275
-2,053
-20% -$61.2K 0.07% 101
2013
Q4
$300K Buy
+10,328
New +$301K 0.09% 101

Other funds holding PFE

Financial & Investment Management Group's PFE Position: Q3 2016 in Review

Financial & Investment Management Group sold out of Pfizer (PFE) in Q3 2016, closing a stake of 8,727 shares — an estimated $292K sold.

Financial & Investment Management Group first reported a position in PFE in Q4 2013 and held it in 10 quarters. The position peaked at $529K in Q1 2015. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

  • Financial & Investment Management Group reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
  • Financial & Investment Management Group sold 8,727 Pfizer shares in Q3 2016, an estimated $292K.
  • Financial & Investment Management Group first reported a position in Pfizer in Q4 2013 and held it in 10 quarters.
  • Financial & Investment Management Group's Pfizer position peaked at $529K in Q1 2015.
  • 1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Financial & Investment Management Group's 13F filing for Q3 2016, filed 17 Oct 2016.